Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201308120 Principal Investigator: Lockhart, A. Craig
Title: A Phase I, open-label, multiple-ascending dose trial to investigate the safety, tolerability, pharmacokinetics, biological and clinical activity of MSB0010718C in subjects with metastatic or locally advanced solid tumors and expansion to selected indications
Phase: I Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to test the investigational drug MSB0010718C given in the treatment of solid tumors at different dose levels to see if it is safe and well tolerated when given once every two weeks. The study is also looking at how MSB0010718C is processed by the body.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)